全球卒中管理市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計中風治療市場將從 2025 年的 493.8 億美元成長到 2034 年的 959.6 億美元，2026 年至 2034 年的複合年成長率為 7.66%。

隨著全球中風病例的不斷增加，全球中風管理市場也穩步擴張。這主要是由於人口老化、不健康的生活方式以及高血壓和糖尿病盛行率的上升。早期診斷和及時介入對於中風治療至關重要，這也推動了對先進影像系統、溶栓藥物和神經血管介入器材的需求。

關鍵成長要素包括微創手術技術的進步和急救回應系統的改進。遠端醫療和遠端監測解決方案的引入提高了獲得專業中風護理的機會，尤其是在農村地區。政府為提高公眾對卒中的認知和實施預防計劃而採取的措施也進一步促進了市場成長。

未來幾年，神經保護藥物和人工智慧診斷工具的創新可望提升治療效果。新興市場醫療基礎設施的不斷改善將創造更多成長機會。隨著人們對早期症狀識別的認知不斷提高，對綜合性中風管理解決方案的需求預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球卒中管理市場：依類型分類

• 市場分析、洞察與預測
• 診斷
• 透過治療方法

第5章 全球卒中管理市場：依應用領域分類

• 市場分析、洞察與預測
• 缺血性中風
• 出血性中風

第6章 全球卒中管理市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Aidoc
  • JLK
  • Deepnoid Co. Ltd
  • VasSol Inc
  • B. Braun SE
  • Cardinal Health
  • Siemens AG
  • Medtronic
  • NeuraSignal Inc
  • Abbott Laboratories
  • METHINKS
  • Boston Scientific Corporation
  • Merck & Co. Inc
  • Heuron Co. Ltd
  • Bristol-Myers Squibb Company

The Stroke Management Market size is expected to reach USD 95.96 Billion in 2034 from USD 49.38 Billion (2025) growing at a CAGR of 7.66% during 2026-2034.

The global stroke management market is expanding steadily due to the rising incidence of stroke cases worldwide. Increasing aging populations, unhealthy lifestyles, and growing prevalence of hypertension and diabetes are major contributing factors. Early diagnosis and timely intervention are critical in stroke treatment, leading to higher demand for advanced imaging systems, thrombolytic drugs, and neurovascular devices.

Major growth drivers include technological advancements in minimally invasive surgical procedures and improved emergency response systems. The adoption of telemedicine and remote monitoring solutions has enhanced access to specialized stroke care, particularly in rural regions. Government initiatives focused on stroke awareness and prevention programs further strengthen market growth.

In the coming years, innovation in neuroprotective drugs and AI-based diagnostic tools is expected to enhance treatment outcomes. Expanding healthcare infrastructure in emerging economies will create additional growth avenues. As awareness about early symptom recognition increases, the demand for comprehensive stroke management solutions will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Diagnostics
• Therapeutics

By Application

• Ischemic Stroke
• Haemorrhagic Stroke

COMPANIES PROFILED

• Aidoc, JLK, Deepnoid Co Ltd, VasSol Inc, B Braun SE, Cardinal Health, Siemens AG, Medtronic, NeuraSignal Inc, Abbott Laboratories, METHINKS, Boston Scientific Corporation, Merck Co Inc, Heuron Co Ltd, BristolMyers Squibb Company
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STROKE MANAGEMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STROKE MANAGEMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Ischemic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Haemorrhagic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STROKE MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL STROKE MANAGEMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Aidoc
  • 8.2.2 JLK
  • 8.2.3 Deepnoid Co. Ltd
  • 8.2.4 VasSol Inc
  • 8.2.5 B. Braun SE
  • 8.2.6 Cardinal Health
  • 8.2.7 Siemens AG
  • 8.2.8 Medtronic
  • 8.2.9 NeuraSignal Inc
  • 8.2.10 Abbott Laboratories
  • 8.2.11 METHINKS
  • 8.2.12 Boston Scientific Corporation
  • 8.2.13 Merck & Co. Inc
  • 8.2.14 Heuron Co. Ltd
  • 8.2.15 Bristol-Myers Squibb Company